ArticleScientific reports2023

Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.

Danny Lascano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.